Related Experiment Video
Updated: Jul 10, 2026

Procedure for Human Saphenous Veins Ex Vivo Perfusion and External Reinforcement
Published on: October 1, 2014
Vascular pleiosynergy--does it really work?
1Department of Medicine, National Health Center, Budapest, Hungary. csaszalb@ogyik.hu
Insights
Multiple cardiovascular risk factors amplify risk, but combined treatments multiply benefits. Some drugs offer additional advantages through pleiotropic effects, a phenomenon termed pleiosynergy, enhancing therapeutic outcomes.
Area of Science:
- Pharmacology
- Cardiovascular Medicine
- Molecular Biology
Background:
- Cardiovascular disease risk escalates with multiple contributing factors.
- Simultaneous treatment of these factors can yield synergistic therapeutic benefits.
- Certain medications possess pleiotropic effects extending beyond their primary therapeutic actions.
Purpose of the Study:
- To define and explore the concept of pleiosynergy in pharmacology.
- To investigate pleiotropic effects of lipid-lowering statins and third-generation calcium channel blockers.
- To understand how these additional effects contribute to overall cardiovascular health.
Main Methods:
- Literature review of studies on statins and calcium channel blockers.
- Analysis of reported pleiotropic mechanisms, including nitric oxide (NO) production, antioxidant activity, and smooth muscle cell modulation.
- Conceptual framework development for pleiosynergy.
Main Results:
- Statins and third-generation calcium channel blockers exhibit significant pleiotropic effects.
- These effects include enhanced endothelial nitric oxide (NO) production, reduced free radical formation, and inhibition of smooth muscle cell migration and proliferation.
- These additional actions are independent of the drugs' primary lipid-lowering or blood pressure-reducing effects.
Conclusions:
- Pleiotropic effects of cardiovascular drugs can lead to 'therapeutic cross effects'.
- This phenomenon, defined as pleiosynergy, enhances overall treatment efficacy.
- Understanding pleiosynergy offers new perspectives for cardiovascular drug development and combination therapy.
Abstract:
Cardiovascular risk increases exponentially by multiple risk factors. Similarly, by simultaneously treating these risk factors the therapeutic benefit can be multiplied. It is also relevant that some drugs exert extra benefit by acting beyond their main effect. A wide range of pleiotropic effects have been reported among lipid lowering statins and third-generation calcium channel blockers. These include an increase of endothelial nitric oxide (NO) production, inhibition of free radical formation and reduction of migration and proliferation of smooth muscle cells independently from the main therapeutic effect of these drugs. Favorable "therapeutic cross effects" due to pleiotropic mechanisms can be defined as pleiosynergy.
Related Concept Videos
Vascular Spasm
Overview of the Vascular System
Cytoskeletal Accessory Proteins
Sympathetic Activation
Varicose Veins I: Introduction
Combined Effects of Drugs: Synergism
Such synergistic combinations...

